{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:50:57Z","timestamp":1761821457645,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Specific Clinical Program of Integrated Traditional Chinese and Western Medicine","award":["ZHYY-ZXJHZX-1-201701"],"award-info":[{"award-number":["ZHYY-ZXJHZX-1-201701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10072-021-05220-3","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T18:02:50Z","timestamp":1617040970000},"page":"2223-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations"],"prefix":"10.1007","volume":"42","author":[{"given":"Ze","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7296-6670","authenticated-orcid":false,"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"issue":"1","key":"5220_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","volume":"15","author":"Joint Task Force of the, E., & the, P. N. S","year":"2010","unstructured":"Joint Task Force of the, E., & the, P. N. S (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. J Peripher Nerv Syst 15(1):1\u20139. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00245.x","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"5220_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.mayocp.2018.03.026","volume":"93","author":"PJB Dyck","year":"2018","unstructured":"Dyck PJB, Tracy JA (2018) History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Mayo Clin Proc 93(6):777\u2013793. https:\/\/doi.org\/10.1016\/j.mayocp.2018.03.026","journal-title":"Mayo Clin Proc"},{"key":"5220_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaut.2019.04.021","volume":"102","author":"Y Rodriguez","year":"2019","unstructured":"Rodriguez Y, Vatti N, Ramirez-Santana C et al (2019) Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. J Autoimmun 102:8\u201337. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.021","journal-title":"J Autoimmun"},{"issue":"9","key":"5220_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","volume":"90","author":"HC Lehmann","year":"2019","unstructured":"Lehmann HC, Burke D, Kuwabara S (2019) Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry 90(9):981\u2013987. https:\/\/doi.org\/10.1136\/jnnp-2019-320314","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5220_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.neuron.2005.10.019","volume":"48","author":"DL Sherman","year":"2005","unstructured":"Sherman DL, Tait S, Melrose S, Johnson R, Zonta B, Court FA, Macklin WB, Meek S, Smith AJH, Cottrell DF, Brophy PJ (2005) Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 48(5):737\u2013742. https:\/\/doi.org\/10.1016\/j.neuron.2005.10.019","journal-title":"Neuron"},{"key":"5220_CR6","doi-asserted-by":"publisher","unstructured":"Stathopoulos P, Alexopoulos H, Dalakas MC (2015) Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nat Rev Neurol 11(3). https:\/\/doi.org\/10.1038\/nrneurol.2014.260","DOI":"10.1038\/nrneurol.2014.260"},{"issue":"1","key":"5220_CR7","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","volume":"7","author":"L Querol","year":"2017","unstructured":"Querol L, Siles AM, Alba-Rovira R, J\u00e1uregui A, Devaux J, Faivre-Sarrailh C, Araque J, Rojas-Garcia R, Diaz-Manera J, Cort\u00e9s-Vicente E, Nogales-Gadea G, Navas-Madro\u00f1al M, Gallardo E, Illa I (2017) Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep 7(1):14411. https:\/\/doi.org\/10.1038\/s41598-017-14853-4","journal-title":"Sci Rep"},{"issue":"10","key":"5220_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","volume":"2","author":"H Ogata","year":"2015","unstructured":"Ogata H, Yamasaki R, Hiwatashi A, Oka N, Kawamura N, Matsuse D, Kuwahara M, Suzuki H, Kusunoki S, Fujimoto Y, Ikezoe K, Kishida H, Tanaka F, Matsushita T, Murai H, Kira JI (2015) Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2(10):960\u2013971. https:\/\/doi.org\/10.1002\/acn3.248","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"5220_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82(10):879\u2013886. https:\/\/doi.org\/10.1212\/WNL.0000000000000205","journal-title":"Neurology"},{"issue":"9","key":"5220_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y, Inoue T, Manso C, Belghazi M, Sekiguchi K, Kokubun N, Ichikawa H, Wong AHY, Yuki N (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 86(9):800\u2013807. https:\/\/doi.org\/10.1212\/WNL.0000000000002418","journal-title":"Neurology"},{"issue":"1-2","key":"5220_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.09.012","volume":"277","author":"W Yan","year":"2014","unstructured":"Yan W, Nguyen T, Yuki N, Ji Q, Yiannikas C, Pollard JD, Mathey EK (2014) Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis. J Neuroimmunol 277(1-2):13\u201317. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.012","journal-title":"J Neuroimmunol"},{"key":"5220_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jneuroim.2017.05.002","volume":"309","author":"EK Mathey","year":"2017","unstructured":"Mathey EK, Garg N, Park SB, Nguyen T, Baker S, Yuki N, Yiannikas C, Lin CS, Spies JM, Ghaoui R, Barnett MH, Vucic S, Pollard JD, Kiernan MC (2017) Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies. J Neuroimmunol 309:41\u201346. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.002","journal-title":"J Neuroimmunol"},{"issue":"6","key":"5220_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","volume":"88","author":"H Koike","year":"2017","unstructured":"Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G (2017) Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry 88(6):465\u2013473. https:\/\/doi.org\/10.1136\/jnnp-2016-314895","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"5220_CR14","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/brain\/awx124","volume":"140","author":"E Delmont","year":"2017","unstructured":"Delmont E, Manso C, Querol L, Cortese A, Berardinelli A, Lozza A, Belghazi M, Malissart P, Labauge P, Taieb G, Yuki N, Illa I, Attarian S, Devaux JJ (2017) Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain 140(7):1851\u20131858. https:\/\/doi.org\/10.1093\/brain\/awx124","journal-title":"Brain"},{"key":"5220_CR15","doi-asserted-by":"publisher","first-page":"6(5)","DOI":"10.1212\/NXI.0000000000000603","volume":"6","author":"H Stengel","year":"2019","unstructured":"Stengel H, Vural A, Brunder AM, Heinius A, Appeltshauser L, Fiebig B, Giese F, Dresel C, Papagianni A, Birklein F, Weis J, Huchtemann T, Schmidt C, K\u00f6rtvelyessy P, Villmann C, Meinl E, Sommer C, Leypoldt F, Doppler K (2019) Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy. Neurol Neuroimmunol Neuroinflamm 6:6(5). https:\/\/doi.org\/10.1212\/NXI.0000000000000603","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"5220_CR16","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","volume":"90","author":"E Burnor","year":"2018","unstructured":"Burnor E, Yang L, Zhou H, Patterson KR, Quinn C, Reilly MM, Rossor AM, Scherer SS, Lancaster E (2018) Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology 90(1):e31\u2013e38. https:\/\/doi.org\/10.1212\/WNL.0000000000004773","journal-title":"Neurology"},{"key":"5220_CR17","doi-asserted-by":"publisher","first-page":"7(1)","DOI":"10.1212\/NXI.0000000000000639","volume":"7","author":"A Cortese","year":"2020","unstructured":"Cortese A, Lombardi R, Briani C, Callegari I, Benedetti L, Manganelli F, Luigetti M, Ferrari S, Clerici AM, Marfia GA, Rigamonti A, Carpo M, Fazio R, Corbo M, Mazzeo A, Giannini F, Cosentino G, Zardini E, Curr\u00f2 R, Gastaldi M, Vegezzi E, Alfonsi E, Berardinelli A, Kouton L, Manso C, Giannotta C, Doneddu P, Dacci P, Piccolo L, Ruiz M, Salvalaggio A, de Michelis C, Spina E, Topa A, Bisogni G, Romano A, Mariotto S, Mataluni G, Cerri F, Stancanelli C, Sabatelli M, Schenone A, Marchioni E, Lauria G, Nobile-Orazio E, Devaux J, Franciotta D (2020) Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm 7:7(1). https:\/\/doi.org\/10.1212\/NXI.0000000000000639","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5220_CR18","doi-asserted-by":"publisher","first-page":"577074","DOI":"10.1016\/j.jneuroim.2019.577074","volume":"337","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zheng P, Devaux JJ, Wang Y, Liu C, Li J, Guo S, Song Y, Wang Q, Feng X, Wang Y (2019) Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China. J Neuroimmunol 337:577074. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577074","journal-title":"J Neuroimmunol"},{"issue":"10","key":"5220_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1115","volume":"8","author":"W Hu","year":"2018","unstructured":"Hu W, Xin Y, He Z, Zhao Y (2018) Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: a systematic review and meta-analysis. Brain Behav 8(10):e01115. https:\/\/doi.org\/10.1002\/brb3.1115","journal-title":"Brain Behav"},{"issue":"5","key":"5220_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/WCO.0000000000000725","volume":"32","author":"E Pascual-Goni","year":"2019","unstructured":"Pascual-Goni E, Martin-Aguilar L, Querol L (2019) Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 32(5):651\u2013657. https:\/\/doi.org\/10.1097\/WCO.0000000000000725","journal-title":"Curr Opin Neurol"},{"key":"5220_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2019.02.045","volume":"63","author":"E Monfrini","year":"2019","unstructured":"Monfrini E, Straniero L, Bonato S, Monzio Compagnoni G, Bordoni A, Dilena R, Rinchetti P, Silipigni R, Ronchi D, Corti S, Comi GP, Bresolin N, Duga S, di Fonzo A (2019) Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy. Parkinsonism Relat Disord 63:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.045","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"5220_CR22","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/brain\/awz248","volume":"142","author":"S Efthymiou","year":"2019","unstructured":"Efthymiou S, Salpietro V, Malintan N, Poncelet M, Kriouile Y, Fortuna S, de Zorzi R, Payne K, Henderson LB, Cortese A, Maddirevula S, Alhashmi N, Wiethoff S, Ryten M, Botia JA, Provitera V, Schuelke M, Vandrovcova J, SYNAPS Study Group, Groppa S, Karashova BM, Nachbauer W, Boesch S, Arning L, Timmann D, Cormand B, P\u00e9rez-Due\u00f1as B, Goraya JS, Sultan T, Mine J, Avdjieva D, Kathom H, Tincheva R, Banu S, Pineda-Marfa M, Veggiotti P, Ferrari MD, van den Maagdenberg AMJM, Verrotti A, Marseglia G, Savasta S, Garc\u00eda-Silva M, Ruiz AM, Garavaglia B, Borgione E, Portaro S, Sanchez BM, Boles R, Papacostas S, Vikelis M, Rothman J, Kullmann D, Papanicolaou EZ, Dardiotis E, Maqbool S, Ibrahim S, Kirmani S, Rana NN, Atawneh O, Lim SY, Shaikh F, Koutsis G, Breza M, Mangano S, Scuderi C, Borgione E, Morello G, Stojkovic T, Zollo M, Heimer G, Dauvilliers YA, Minetti C, al-Khawaja I, al-Mutairi F, Hamed S, Pipis M, Bettencourt C, Rinaldi S, Walsh L, Torti E, Iodice V, Najafi M, Karimiani EG, Maroofian R, Siquier-Pernet K, Boddaert N, de Lonlay P, Cantagrel V, Aguennouz M, el Khorassani M, Schmidts M, Alkuraya FS, Edvardson S, Nolano M, Devaux J, Houlden H (2019) Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination. Brain 142(10):2948\u20132964. https:\/\/doi.org\/10.1093\/brain\/awz248","journal-title":"Brain"},{"issue":"2","key":"5220_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1073858417710897","volume":"24","author":"A Ghosh","year":"2018","unstructured":"Ghosh A, Sherman DL, Brophy PJ (2018) The axonal cytoskeleton and the assembly of nodes of Ranvier. Neuroscientist 24(2):104\u2013110. https:\/\/doi.org\/10.1177\/1073858417710897","journal-title":"Neuroscientist"},{"issue":"14","key":"5220_CR24","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1523\/Jneurosci.5951-09.2010","volume":"30","author":"C Thaxton","year":"2010","unstructured":"Thaxton C, Pillai AM, Pribisko AL, Labasque M, Dupree JL, Faivre-Sarrailh C, Bhat MA (2010) In vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axons. J Neurosci 30(14):4868\u20134876. https:\/\/doi.org\/10.1523\/Jneurosci.5951-09.2010","journal-title":"J Neurosci"},{"issue":"21","key":"5220_CR25","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1093\/hmg\/ddy277","volume":"27","author":"R Smigiel","year":"2018","unstructured":"Smigiel R, Sherman DL, Rydzanicz M, Walczak A, Mikolajkow D, Krolak-Olejnik B, Kosi\u0144ska J, Gasperowicz P, Biernacka A, Stawinski P, Marciniak M, Andrzejewski W, Boczar M, Krajewski P, Sasiadek MM, Brophy PJ, Ploski R (2018) Homozygous mutation in the Neurofascin gene affecting the glial isoform of Neurofascin causes severe neurodevelopment disorder with hypotonia, amimia and areflexia. Hum Mol Genet 27(21):3669\u20133674. https:\/\/doi.org\/10.1093\/hmg\/ddy277","journal-title":"Hum Mol Genet"},{"issue":"2","key":"5220_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/gim.2016.95","volume":"19","author":"KD Farwell Hagman","year":"2017","unstructured":"Farwell Hagman KD, Shinde DN, Mroske C, Smith E, Radtke K, Shahmirzadi L, el-Khechen D, Powis Z, Chao EC, Alcaraz WA, Helbig KL, Sajan SA, Rossi M, Lu HM, Huether R, Li S, Wu S, Nu\u00f1es ME, Tang S (2017) Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. Genet Med 19(2):224\u2013235. https:\/\/doi.org\/10.1038\/gim.2016.95","journal-title":"Genet Med"},{"issue":"1","key":"5220_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","volume":"14","author":"L Martinez-Martinez","year":"2017","unstructured":"Martinez-Martinez L, Lleixa MC, Boera-Carnicero G et al (2017) Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15. J Neuroinflammation 14(1):224. https:\/\/doi.org\/10.1186\/s12974-017-0996-1","journal-title":"J Neuroinflammation"},{"key":"5220_CR28","doi-asserted-by":"publisher","first-page":"577139","DOI":"10.1016\/j.jneuroim.2019.577139","volume":"339","author":"H Ogata","year":"2020","unstructured":"Ogata H, Isobe N, Zhang X, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Kira JI (2020) Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 339:577139. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577139","journal-title":"J Neuroimmunol"},{"issue":"10","key":"5220_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","volume":"74","author":"L Gragert","year":"2013","unstructured":"Gragert L, Madbouly A, Freeman J, Maiers M (2013) Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol 74(10):1313\u20131320. https:\/\/doi.org\/10.1016\/j.humimm.2013.06.025","journal-title":"Hum Immunol"},{"issue":"2","key":"5220_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2004.10.004","volume":"119","author":"F Ango","year":"2004","unstructured":"Ango F, di Cristo G, Higashiyama H, Bennett V, Wu P, Huang ZJ (2004) Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at Purkinje axon initial segment. Cell 119(2):257\u2013272. https:\/\/doi.org\/10.1016\/j.cell.2004.10.004","journal-title":"Cell"},{"issue":"1","key":"5220_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1074\/jbc.M110.180281","volume":"286","author":"H Liu","year":"2011","unstructured":"Liu H, Focia PJ, He X (2011) Homophilic adhesion mechanism of neurofascin, a member of the L1 family of neural cell adhesion molecules. J Biol Chem 286(1):797\u2013805. https:\/\/doi.org\/10.1074\/jbc.M110.180281","journal-title":"J Biol Chem"},{"issue":"1","key":"5220_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.mcn.2005.06.007","volume":"30","author":"D Koticha","year":"2005","unstructured":"Koticha D, Babiarz J, Kane-Goldsmith N, Jacob J, Raju K, Grumet M (2005) Cell adhesion and neurite outgrowth are promoted by neurofascin NF155 and inhibited by NF186. Mol Cell Neurosci 30(1):137\u2013148. https:\/\/doi.org\/10.1016\/j.mcn.2005.06.007","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"5220_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.biocel.2012.01.012","volume":"44","author":"M Kriebel","year":"2012","unstructured":"Kriebel M, Wuchter J, Trinks S, Volkmer H (2012) Neurofascin: a switch between neuronal plasticity and stability. Int J Biochem Cell Biol 44(5):694\u2013697. https:\/\/doi.org\/10.1016\/j.biocel.2012.01.012","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"5220_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuron.2010.02.004","volume":"65","author":"K Feinberg","year":"2010","unstructured":"Feinberg K, Eshed-Eisenbach Y, Frechter S, Amor V, Salomon D, Sabanay H, Dupree JL, Grumet M, Brophy PJ, Shrager P, Peles E (2010) A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier. Neuron 65(4):490\u2013502. https:\/\/doi.org\/10.1016\/j.neuron.2010.02.004","journal-title":"Neuron"},{"issue":"23","key":"5220_CR35","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JKM Ng","year":"2012","unstructured":"Ng JKM, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Pruss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79(23):2241\u20132248. https:\/\/doi.org\/10.1212\/WNL.0b013e31827689ad","journal-title":"Neurology"},{"issue":"11","key":"5220_CR36","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/jnnp-2018-318170","volume":"89","author":"K Doppler","year":"2018","unstructured":"Doppler K, Stengel H, Appeltshauser L, Grosskreutz J, Man Ng JK, Meinl E, Sommer C (2018) Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies. J Neurol Neurosurg Psychiatry 89(11):1145\u20131151. https:\/\/doi.org\/10.1136\/jnnp-2018-318170","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5220_CR37","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1523\/JNEUROSCI.3552-14.2015","volume":"35","author":"A Zhang","year":"2015","unstructured":"Zhang A, Desmazieres A, Zonta B, Melrose S, Campbell G, Mahad D, Li Q, Sherman DL, Reynolds R, Brophy PJ (2015) Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of Ranvier. J Neurosci 35(5):2246\u20132254. https:\/\/doi.org\/10.1523\/JNEUROSCI.3552-14.2015","journal-title":"J Neurosci"},{"key":"5220_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2013.00235","volume":"4","author":"AM Collins","year":"2013","unstructured":"Collins AM, Jackson KJ (2013) A temporal model of human IgE and IgG antibody function. Front Immunol 4:235. https:\/\/doi.org\/10.3389\/fimmu.2013.00235","journal-title":"Front Immunol"},{"issue":"1","key":"5220_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.13561","volume":"1413","author":"MG Huijbers","year":"2018","unstructured":"Huijbers MG, Plomp JJ, van der Maarel SM, Verschuuren JJ (2018) IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. Ann N Y Acad Sci 1413(1):92\u2013103. https:\/\/doi.org\/10.1111\/nyas.13561","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5220_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0036-1584322","volume":"36","author":"LC Lighaam","year":"2016","unstructured":"Lighaam LC, Rispens T (2016) The Immunobiology of Immunoglobulin G4. Semin Liver Dis 36(3):200\u2013215. https:\/\/doi.org\/10.1055\/s-0036-1584322","journal-title":"Semin Liver Dis"},{"key":"5220_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","volume":"9","author":"I Koneczny","year":"2018","unstructured":"Koneczny I (2018) A New Classification System for IgG4 Autoantibodies. Front Immunol 9:97. https:\/\/doi.org\/10.3389\/fimmu.2018.00097","journal-title":"Front Immunol"},{"issue":"3","key":"5220_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0960-9822(01)00680-7","volume":"12","author":"P Charles","year":"2002","unstructured":"Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, Denisenko-Nehrbass N, Guennoc AM, Girault JA, Brophy PJ, Lubetzki C (2002) Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction. Curr Biol 12(3):217\u2013220. https:\/\/doi.org\/10.1016\/s0960-9822(01)00680-7","journal-title":"Curr Biol"},{"issue":"3","key":"5220_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","volume":"27","author":"JM Vallat","year":"2017","unstructured":"Vallat JM, Yuki N, Sekiguchi K, Kokubun N, Oka N, Mathis S, Magy L, Sherman DL, Brophy PJ, Devaux JJ (2017) Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies. Neuromuscul Disord 27(3):290\u2013293. https:\/\/doi.org\/10.1016\/j.nmd.2016.10.008","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"5220_CR44","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","volume":"2","author":"L Querol","year":"2015","unstructured":"Querol L, Rojas-Garcia R, Diaz-Manera J et al (2015) Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm 2(5):e149. https:\/\/doi.org\/10.1212\/NXI.0000000000000149","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5220_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2017.11.035","volume":"384","author":"A Fujita","year":"2018","unstructured":"Fujita A, Ogata H, Yamasaki R, Matsushita T, Kira JI (2018) Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 384:107\u2013112. https:\/\/doi.org\/10.1016\/j.jns.2017.11.035","journal-title":"J Neurol Sci"},{"issue":"5","key":"5220_CR46","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/mus.26010","volume":"57","author":"N Garg","year":"2018","unstructured":"Garg N, Park SB, Yiannikas C, Vucic S, Howells J, Noto YI, Mathey EK, Pollard JD, Kiernan MC (2018) Neurofascin-155 IGG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment. Muscle Nerve 57(5):848\u2013851. https:\/\/doi.org\/10.1002\/mus.26010","journal-title":"Muscle Nerve"},{"key":"5220_CR47","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520. https:\/\/doi.org\/10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"issue":"11","key":"5220_CR48","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1136\/jnnp-2012-303013","volume":"84","author":"TA Saifee","year":"2013","unstructured":"Saifee TA, Schwingenschuh P, Reilly MM, Lunn MPT, Katschnig P, Kassavetis P, Pare\u00e9s I, Manji H, Bhatia K, Rothwell JC, Edwards MJ (2013) Tremor in inflammatory neuropathies. J Neurol Neurosurg Psychiatry 84(11):1282\u20131287. https:\/\/doi.org\/10.1136\/jnnp-2012-303013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"5220_CR49","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1212\/WNL.0b013e318292a2b8","volume":"80","author":"P Schwingenschuh","year":"2013","unstructured":"Schwingenschuh P, Saifee TA, Katschnig-Winter P, Reilly MM, Lunn MP, Manji H, Aguirregomozcorta M, Schmidt R, Bhatia KP, Rothwell JC, Edwards MJ (2013) Cerebellar learning distinguishes inflammatory neuropathy with and without tremor. Neurology 80(20):1867\u20131873. https:\/\/doi.org\/10.1212\/WNL.0b013e318292a2b8","journal-title":"Neurology"},{"issue":"1","key":"5220_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp-2014-309831","volume":"87","author":"H Ogata","year":"2016","unstructured":"Ogata H, Matsuse D, Yamasaki R, Kawamura N, Matsushita T, Yonekawa T, Hirotani M, Murai H, Kira JI (2016) A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry 87(1):29\u201336. https:\/\/doi.org\/10.1136\/jnnp-2014-309831","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5220_CR51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jns.2016.02.022","volume":"363","author":"A Cortese","year":"2016","unstructured":"Cortese A, Franciotta D, Alfonsi E, Visigalli N, Zardini E, Diamanti L, Prunetti P, Osera C, Gastaldi M, Berzero G, Pichiecchio A, Piccolo G, Lozza A, Piscosquito G, Salsano E, Ceroni M, Moglia A, Bono G, Pareyson D, Marchioni E (2016) Combined central and peripheral demyelination: clinical features, diagnostic findings, and treatment. J Neurol Sci 363:182\u2013187. https:\/\/doi.org\/10.1016\/j.jns.2016.02.022","journal-title":"J Neurol Sci"},{"issue":"8","key":"5220_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","volume":"81","author":"N Kawamura","year":"2013","unstructured":"Kawamura N, Yamasaki R, Yonekawa T, Matsushita T, Kusunoki S, Nagayama S, Fukuda Y, Ogata H, Matsuse D, Murai H, Kira JI (2013) Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 81(8):714\u2013722. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a1aa9c","journal-title":"Neurology"},{"issue":"11","key":"5220_CR53","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/acn3.51220","volume":"7","author":"H Ogata","year":"2020","unstructured":"Ogata H, Zhang X, Inamizu S, Yamashita KI, Yamasaki R, Matsushita T, Isobe N, Hiwatashi A, Tobimatsu S, Kira JI (2020) Optic, trigeminal, and facial neuropathy related to anti-neurofascin 155 antibody. Ann Clin Transl Neurol 7(11):2297\u20132309. https:\/\/doi.org\/10.1002\/acn3.51220","journal-title":"Ann Clin Transl Neurol"},{"key":"5220_CR54","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fneur.2017.00724","volume":"8","author":"J Klehmet","year":"2017","unstructured":"Klehmet J, Staudt M, Diederich JM, Siebert E, Meinl E, Harms L, Meisel A (2017) Neurofascin (NF)155- and NF186-specific T cell response in a patient developing a central pontocerebellar demyelination after 10 years of CIDP. Front Neurol 8:724. https:\/\/doi.org\/10.3389\/fneur.2017.00724","journal-title":"Front Neurol"},{"key":"5220_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.msard.2019.02.026","volume":"30","author":"N Suanprasert","year":"2019","unstructured":"Suanprasert N, Taylor BV, Klein CJ, Roforth MM, Karam C, Keegan BM, Dyck PJB (2019) Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis. Mult Scler Relat Disord 30:284\u2013290. https:\/\/doi.org\/10.1016\/j.msard.2019.02.026","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"5220_CR56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.150.3.657","volume":"150","author":"S Tait","year":"2000","unstructured":"Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, Pedraza L, Sherman DL, Colman DR, Brophy PJ (2000) An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 150(3):657\u2013666. https:\/\/doi.org\/10.1083\/jcb.150.3.657","journal-title":"J Cell Biol"},{"issue":"4","key":"5220_CR57","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","volume":"131","author":"L Kouton","year":"2020","unstructured":"Kouton L, Boucraut J, Devaux J, Rajabally YA, Adams D, Antoine JC, Bourdain F, Brodovitch A, Camdessanch\u00e9 JP, Cauquil C, Ciron J, Dubard T, Echaniz-Laguna A, Grapperon AM, Juntas-Morales R, Kremer L, Kuntzer T, Labeyrie C, Lanfranco L, L\u00e9ger JM, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Merle P, Noury JB, Rouaud V, Tard C, Th\u00e9audin M, Vallat JM, Viala K, Attarian S, Delmont E (2020) Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins. Clin Neurophysiol 131(4):921\u2013927. https:\/\/doi.org\/10.1016\/j.clinph.2020.01.013","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"5220_CR58","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini A, Kuwabara S (2015) Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry 86(11):1186\u20131195. https:\/\/doi.org\/10.1136\/jnnp-2014-310097","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5220_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","volume":"89","author":"J Fehmi","year":"2018","unstructured":"Fehmi J, Scherer SS, Willison HJ, Rinaldi S (2018) Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry 89(1):61\u201371. https:\/\/doi.org\/10.1136\/jnnp-2016-315480","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5220_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2019.01.017","volume":"330","author":"C Briani","year":"2019","unstructured":"Briani C, Salvalaggio A, Ruiz M, Cacciavillani M, Rinaldi F, Callegari I, Gasparotti R, Franciotta D (2019) Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy. J Neuroimmunol 330:178\u2013180. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.017","journal-title":"J Neuroimmunol"},{"issue":"7","key":"5220_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy134","volume":"141","author":"JM Vallat","year":"2018","unstructured":"Vallat JM, Mathis S, Magy L, Bounolleau P, Skarzynski M, Heitzmann A, Manso C, Devaux J, Uncini A (2018) Subacute nodopathy with conduction blocks and anti-neurofascin 140\/186 antibodies: an ultrastructural study. Brain 141(7):e56. https:\/\/doi.org\/10.1093\/brain\/awy134","journal-title":"Brain"},{"key":"5220_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fncel.2017.00011","volume":"11","author":"AM Taylor","year":"2017","unstructured":"Taylor AM, Saifetiarova J, Bhat MA (2017) Postnatal loss of neuronal and glial neurofascins differentially affects node of ranvier maintenance and myelinated axon function. Front Cell Neurosci 11:11. https:\/\/doi.org\/10.3389\/fncel.2017.00011","journal-title":"Front Cell Neurosci"},{"key":"5220_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","volume":"301","author":"M Kadoya","year":"2016","unstructured":"Kadoya M, Kaida K, Koike H, Takazaki H, Ogata H, Moriguchi K, Shimizu J, Nagata E, Takizawa S, Chiba A, Yamasaki R, Kira JI, Sobue G, Ikewaki K (2016) IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol 301:16\u201322. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.013","journal-title":"J Neuroimmunol"},{"issue":"3","key":"5220_CR64","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ, on behalf of British Committee for Standards in Haematology (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158(3):323\u2013335. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09167.x","journal-title":"Br J Haematol"},{"issue":"3","key":"5220_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","volume":"29","author":"M Hertl","year":"2015","unstructured":"Hertl M, Jedlickova H, Karpati S, Marinovic B, Uzun S, Yayli S, Mimouni D, Borradori L, Feliciani C, Ioannides D, Joly P, Kowalewski C, Zambruno G, Zillikens D, Jonkman MF (2015) Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 29(3):405\u2013414. https:\/\/doi.org\/10.1111\/jdv.12772","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"5220_CR66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mdc3.12662","volume":"5","author":"C Demichelis","year":"2018","unstructured":"Demichelis C, Franciotta D, Cortese A, Callegari I, Serrati C, Mancardi GL, Schenone A, Leonardi A, Benedetti L (2018) Remarkable rituximab response on tremor related to acute-onset chronic inflammatory demyelinating polyradiculoneuropathy in an antineurofascin155 immunoglobulin g4-seropositive patient. Mov Disord Clin Pract 5(5):559\u2013560. https:\/\/doi.org\/10.1002\/mdc3.12662","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"5220_CR67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejpn.2011.08.002","volume":"16","author":"A D'Amico","year":"2012","unstructured":"D'Amico A, Catteruccia M, De Benedetti F et al (2012) Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy. Eur J Paediatr Neurol 16(3):301\u2013303. https:\/\/doi.org\/10.1016\/j.ejpn.2011.08.002","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"5220_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pediatrneurol.2006.09.012","volume":"36","author":"E Rossignol","year":"2007","unstructured":"Rossignol E, D'Anjou G, Lapointe N, Haddad E, Vanasse M (2007) Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr Neurol 36(2):88\u201394. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2006.09.012","journal-title":"Pediatr Neurol"},{"issue":"1-2","key":"5220_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.02.027","volume":"256","author":"C Munch","year":"2007","unstructured":"Munch C, Anagnostou P, Meyer R, Haas J (2007) Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus. J Neurol Sci 256(1-2):100\u2013102. https:\/\/doi.org\/10.1016\/j.jns.2007.02.027","journal-title":"J Neurol Sci"},{"issue":"12","key":"5220_CR70","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1111\/ene.14498","volume":"27","author":"S Casertano","year":"2020","unstructured":"Casertano S, Signoriello E, Rossi F, di Pietro A, Tuccillo F, Bonavita S, Lus G (2020) Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies. Eur J Neurol 27(12):2673\u20132675. https:\/\/doi.org\/10.1111\/ene.14498","journal-title":"Eur J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05220-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T07:36:17Z","timestamp":1622100977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05220-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5220"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05220-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}